Contents
pages ii-iii
Full-Text PDF (41 KB)

Cell Death Mechanisms and Modulation in Traumatic Brain Injury
Bogdan A. Stoica, Alan I. Faden
pages 3-12
Abstract | Full Text | Full-Text PDF (483 KB)

Involvement of Pro- and Anti-Inflammatory Cytokines and Chemokines in the Pathophysiology of Traumatic Brain Injury
Jenna M. Ziebell, Maria Cristina Morganti-Kossmann
pages 22-30
Abstract | Full Text | Full-Text PDF (424 KB)

The Evidence for Hypothermia as a Neuroprotectant in Traumatic Brain Injury
W. Dalton Dietrich, Helen M. Bramlett
pages 43-50
Abstract | Full Text | Full-Text PDF (204 KB)

Statins in Traumatic Brain Injury
Elissa F. Wible, Daniel T. Laskowitz
pages 62-73
Abstract | Full Text | Full-Text PDF (443 KB)

Traumatic Brain Injury and Aging: Is a Combination of Progesterone and Vitamin D Hormone a Simple Solution to a Complex Problem?
Milos Cekic, Donald G. Stein
pages 81-90
Abstract | Full Text | Full-Text PDF (285 KB)

Biomarkers for the Diagnosis, Prognosis, and Evaluation of Treatment Efficacy for Traumatic Brain Injury
Pramod K. Dash, Jing Zhao, Georgene Hergenroeder, Anthony N. Moore
pages 100-114
Abstract | Full Text | Full-Text PDF (414 KB)

IMPACT Recommendations for Improving the Design and Analysis of Clinical Trials in Moderate to Severe Traumatic Brain Injury
Andrew I.R. Maas, Ewout W. Steyerberg, Anthony Marmarou, Gillian S. McHugh, Hester F. Lingsma, Isabella Butcher, Juan Lu, James Weir, Bob Roozenbeek, Gordon D. Murray
pages 127-134
Abstract | Full Text | Full-Text PDF (184 KB)

Introduction—Introduction and acknowledgments
Jang-Ho Cha, Richard Dubinsky
page 135
Full-Text PDF (79 KB)

Platform presentation—Early Defect of Transforming Growth Factor β1 Formation in Huntington's Disease
G. Battaglia, M. Cannella, B. Riozzi, S. Orobello, M.L. Maat-Schieman, E. Aronica, C. Letizia Busceti, A. Ciarmiello, S. Alberti, J. Sassone, S. Sipione, V. Bruno, L. Frati, F. Nicoletti, F. Squitieri
pages 135-136
Abstract | Full-Text PDF (101 KB)

Break and poster viewing
page 136
Full-Text PDF (84 KB)

Platform presentation—Early vs Late Huntington's Disease: Is There a Difference in Psychiatric Symptom Severity?
K. Anderson, A. Gruber-Baldini, J. Medalie, S. Reich, P. Fishman, B. Robottom, W. Weiner, L. Shulman
page 136
Abstract | Full-Text PDF (84 KB)

Keynote address—FDA Regulation of Stem Cell Therapy
Celia Witten
page 137
Abstract | Full-Text PDF (76 KB)

Poster 2: Genetic Discrimination of Individuals at Risk of Huntington's Disease: Further Analysis of the RESPOND-HD Data From Australia (Site 144)
A. Goh, O. Yastrubetskaya, E. Chiu
page 138
Abstract | Full-Text PDF (83 KB)

Poster 4: The Effect of Video Game-Based Exercise on Dynamic Balance and Mobility in Individuals with Huntington's Disease
D. Kegelmeyer, S. Kostyk, N. Fritz, A. Kloos
page 139
Abstract | Full-Text PDF (81 KB)

Poster 6: Cerebrospinal Fluid (CSF) Volume Is the Main Marker of Huntington Disease Progression Severity and Age-at-Onset Prediction
F. Squitieri, M. Cannella, M. Simonelli, T. Martino, C. Colonnese, A. Ciarmiello
pages 139-140
Abstract | Full-Text PDF (104 KB)

Poster 8: Reliability of the Problem Behaviours Assessment for HD (short version)–Data From the TRACK-HD Study
J. Callaghan, N. Arran, M.F. Boisse, A. Coleman, R. Dar Santos, E. Dumas, E. 't Hart, D. Justo, J. Read, M. Say, S. Van Den Bogaard, A. Durr, B. Leavitt, R. Roos, S. Tabrizi, C. Bourdet, E. van Duijn, D. Craufurd, TRACK-HD Investigators
page 140
Abstract | Full-Text PDF (87 KB)

Poster 10: Degree of Disability Is Predictive of Physical But Not Mental Health Quality of Life in Huntington's Disease
B. Robottom, K. Anderson, J. Medalie, A. Gruber-Baldini, P. Fishman, S. Reich, W. Weiner, L. Shulman
page 141
Abstract | Full-Text PDF (85 KB)

Poster 12: Self-Efficacy in Health Behaviors: Is There a Difference in Huntington vs Parkinson Disease?
A. Mitchell, K. Anderson, J. Medalie, A. Gruber-Baldini, B. Robottom, P. Fishman, S. Reich, W. Weiner, L. Shulman
pages 141-142
Abstract | Full-Text PDF (104 KB)

Poster 14: Evaluation of Novel Radiotracers Targeting Non-Dopaminergic Striatal Biomarkers in HD: 18F-FPEB and PET Imaging for Metabotropic Glutamate Receptor Type 5 (mGluR5) Expression in Healthy Subjects and Subjects with Huntington Disease (HD)
D. Russell, D. Jennings, G. Tamagnan, J. Seibyl, A. Koren, G. Zubal, K. Marek
page 142
Abstract | Full-Text PDF (84 KB)

Poster 16: Genetic Approach to Huntington's Disease Therapeutics
M. MacDonald, J. Min Lee, I. Sik Seong, E. Fossale, M.A. Anderson, V. Wheeler, J. Gusella
page 143
Abstract | Full-Text PDF (76 KB)

Poster 18: Lack of Awareness of Motor and Cognitive Phenoconversion in Huntington's Disease
K. Richardson, E. McCusker, C. Loy, J. Griffith, J. Mills, J.S. Paulsen, PREDICT-HD Investigators of the Huntington Study Group
page 144
Abstract | Full-Text PDF (83 KB)

Poster 20: Pridopidine (ACR16) in Huntington's Disease: An Update on the MermaiHD and HART Studies
J. Tedroff, P. Lindskov Krogh, A. Buusman, Å. Rembratt
pages 144-145
Abstract | Full-Text PDF (100 KB)

Poster 22: The Huntington Self-Assessment Instrument (HSAI): A Comprehensive and Specific Tool to Measure the Burden of Huntington's Disease
J. Tedroff, J. Dorey, M. Lamure, J.-M. Graf von der Schulenburg, M. Toumi
page 145
Abstract | Full-Text PDF (84 KB)

Poster 24: Worry and Experience of Genetic Discrimination in Persons at Risk for Huntington Disease
C. Erwin, J. Williams, A. Juhl, J. Paulsen, Investigators of the Huntington Study Group
page 146
Abstract | Full-Text PDF (84 KB)

Poster 26: Word Reading Compared to Demographics-Based Estimates of Premorbid IQ in Early Huntington Disease
W. Adams, J. Byars, J. O'Rourke, A. Flynn, J. Fiedorowicz, K. Duff, A. Leserman, P. Nopoulos, L. Beglinger
pages 146-147
Abstract | Full-Text PDF (102 KB)

Poster 28: Delphi Process for the Development of Treatment Guidelines for Behavioral Symptoms and Chorea in Huntington's Disease
E. van Duijn, M. Groves, D. Craufurd, K. Anderson, M. Guttman, E. Wexler, S. Perlman, J.-M. Burgunder, A. Rosenblatt, D. van Kammen, J. Giuliano, L. Goodman
page 147
Abstract | Full-Text PDF (85 KB)